Filing Details

Accession Number:
0001209191-19-018293
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-08 19:29:44
Reporting Period:
2019-03-07
Accepted Time:
2019-03-08 19:29:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1610618 Cidara Therapeutics Inc. CDTX Biological Products, (No Disgnostic Substances) (2836) 461537286
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1639144 Paul Daruwala 6310 Nancy Ridge Drive
Suite 101
San Diego CA 92121
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-03-07 2,240 $2.55 49,567 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold to cover the tax obligation that occurred upon the vesting of restricted stock units.